The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood Pressure-Reference-Cited by-同舟云学术

The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood Pressure

Published:2016-08-25 Issue:3 Volume:19 Page:312-321
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Perez Alfonso¹,Cao Charlie¹

Affiliation:

1. Takeda Development Center Americas, Inc.; Deerfield IL

Funder

Takeda Pharmaceuticals U.S.A.

Absolute Healthcare Communications Ltd

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.12895/fullpdf

Reference34 articles.

1. Rationale for triple-combination therapy for management of high blood pressure;Gradman;J Clin Hypertens (Greenwich),2010

2. Combination therapy in hypertension;Gradman;J Am Soc Hypertens,2010

3. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people;Rapsomaniki;Lancet,2014

4. Comparative safety and tolerability of angiotensin II receptor antagonists;Mazzolai;Drug Saf,1999

5. Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis;Ross;Pharmacotherapy,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-04

2. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03

3. Changing Concepts About Optimal Target Blood Pressure and the Therapeutic Advantages of Azilsartan for Achieving it;Kardiologiia;2024-04-30

4. Is the newest angiotensin‐receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta‐analysis;The Journal of Clinical Hypertension;2021-02-20

5. Single-pill Combination Therapy of Azilsartan Medoxomil/Chlorthalidone for Treatment of Hypertension: A Systematic Review;Clinical Therapeutics;2020-07